Lewy body dementia trials in Taiwan

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  Where

  New Taipei City, Tainan, Taipei, Taoyuan

  Age

  55 years to 85 years

  People

  350 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07589595